Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 cases.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Urology

• Publication date

  2001-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(05)65722-9PMID 11586262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bone morphogenetic protein-6 expression in normal and malignant prostate

  2004cited by this paper
• Pathogenesis of Bone Metastases: Role of Tumor‐Related Proteins

  2000cited by this paper
• Increased Expression of Bone Sialoprotein in Bone Metastases Compared with Visceral Metastases in Human Breast and Prostate Cancers

  2000cited by this paper
• The potential role of bisphosphonates as adjuvant therapy in the prevention of bone metastases

  2000cited by this paper
• Staging prostate cancer

  2000cited by this paper
• Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.

  1999cited by this paper
• Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor

  1999cited by this paper
• Expression of platelet-derived endothelial cell growth factor in prostatic adenocarcinoma.

  1999cited by this paper
• Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

  1999cited by this paper
• Microvessel density in prostate cancer: prognostic and therapeutic utility.

  1998cited by this paper
• Pharmacology and clinical efficacy of bisphosphonates.

  1998cited by this paper
• Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer.

  1998cited by this paper
• Ectopic Expression of Bone Sialoprotein in Human Thyroid Cancer

  1998cited by this paper
• Evidence that breast cancer associated microcalcifications are mineralized malignant cells.

  1998cited by this paper
• Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.

  1998cited by this paper
• Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas.

  1998cited by this paper
• Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.

  1998cited by this paper
• Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers

  1997cited by this paper
• Expression of Bone Sialoprotein in Human Lung Cancer

  1997cited by this paper
• Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.

  1997cited by this paper
• Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.

  1997cited by this paper
• Mechanisms of bone metastasis

  1997cited by this paper
• Staging prostate cancer--1997: current methods and limitations.

  1997cited by this paper
• Mechanisms of the development of osteoblastic metastases

  1997cited by this paper
• Characterization of Native and Recombinant Bone Sialoprotein: Delineation of the Mineral‐Binding and Cell Adhesion Domains and Structural Analysis of the RGD Domain

  1997cited by this paper
• Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.

  1997cited by this paper
• Time-dependent expression of bone sialoprotein fragments in osteogenesis induced by bone morphogenetic protein.

  1996cited by this paper
• Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone.

  1996cited by this paper
• The activity and expression of thymidine phosphorylase in human solid tumours.

  1996cited by this paper
• Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development

  1996cited by this paper
• Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6.

  1996cited by this paper
• The function of the vertebral veins and their role in the spread of metastases. 1940.

  1995cited by this paper
• Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells.

  1995cited by this paper
• Platelet‐derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study

  1995cited by this paper
• Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins.

  1995cited by this paper
• Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells

  1994cited by this paper
• WHY DOES BONE MATRIX CONTAIN NON‐COLLAGENOUS PROTEINS? THE POSSIBLE ROLES OF OSTEOCALCIN, OSTEONECTIN, OSTEOPONTIN AND BONE SIALOPROTEIN IN BONE MINERALISATION AND RESORPTION

  1994cited by this paper
• Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein, DVR-6 (bone morphogenetic protein-6)

  1993cited by this paper
• Purification and fragmentation of nondenatured bone sialoprotein: Evidence for a cryptic, RGD‐resistant cell attachment domain

  1993cited by this paper
• Analysis of bone metastasis of prostatic adenocarcinoma in 137 autopsy cases.

  1992cited by this paper
• Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia.

  1992cited by this paper
• Expression of bone sialoprotein (BSP) in developing human tissues

  1991cited by this paper
• Matrix sialoprotein of developing bone.

  1983cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES

  1940cited by this paper

• Small Integrin binding Ligand N-linked Glycoproteins, prostate-specific antigen and time to prostate cancer diagnosis

  2025cites this paper
• The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery

  2023cites this paper
• Focal Increased Radiopharmaceutical Uptake Differentiation Using Quantitative Indices

  2021cites this paper
• Temporal Scintimetric Characterization of Skeletal Hotspots in Bone Scan by Dr. V. Siva’s Retention Ratio

  2016cites this paper
• The activity of the TGF beta superfamily in prostate cancer and the formation of bone metastases.

  2015cites this paper
• Chapter 12 – Bone remodeling markers and bone cancer

  2015cites this paper
• Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2.

  2013cites this paper
• Molecular diagnosis of prostate cancer: are we up to age?

  2013cites this paper
• Diagnostic and prognostic use of bone turnover markers.

  2012cites this paper
• Bone Remodeling Markers and Bone Cancer

  2010cites this paper
• Die Rolle der Knochenumbaumarker bei Knochenmetastasen

  2009cites this paper
• Molecular diagnosis in prostate cancer : PCA3

  2009cites this paper
• Immunolocalization and mRNA Expression of Bone Morphogenetic Protein-6 in Human Clear Cell Renal Carcinoma

  2009cites this paper
• BMP‐6 over‐expression in prostate cancer is associated with increased Id‐1 protein and a more invasive phenotype

  2008cites this paper
• The use of molecular markers of bone turnover in the management of patients with metastatic bone disease

  2008cites this paper
• Activins, Inhibins, and Bone Morphogenetic Proteins as Modulators and Biomarkers of Prostate Cancer Progression

  2008cites this paper
• CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.

  2008cites this paper
• The essential role of bone morphogenetic protein (BMP) signaling in organogenesis

  2007cites this paper
• Bone morphogenetic proteins and their receptor signaling in prostate cancer.

  2007cites this paper
• Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).

  2007cites this paper
• [Molecular aspects of prostate cancer: recent data from the literature].

  2007cites this paper
• Bone morphogenetic proteins in melanoma: Angel or devil?

  2005cites this paper
• Clinical use of markers of bone turnover in metastatic bone disease

  2005cites this paper
• Molecular Diagnostics in Prostate Cancer

  2005cites this paper
• Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.

  2005cites this paper
• Molecular profile of androgen-independent prostate cancer xenograft LuCaP 23.1.

  2005cites this paper
• Bone Morphogenetic Protein (BMP)-6 Signaling and BMP Antagonist Noggin in Prostate Cancer

  2004cites this paper
• Human prostate cancer risk factors

  2004cites this paper
• Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells.

  2004cites this paper
• Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma

  2004cites this paper
• Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.

  2004cites this paper
• Clinical review 165: Markers of bone remodeling in metastatic bone disease.

  2003cites this paper
• Detection of Bone Sialoprotein in Human (Pre)neoplastic Lesions of the Uterine Cervix

  2003cites this paper
• IL‐18 is produced by prostate cancer cells and secreted in response to interferons

  2003cites this paper
• Markers of Bone Remodeling in Metastatic Bone Disease

  2003cites this paper
• Staging in prostate cancer

  2002cites this paper
• Physiopathology of cancer metastases in bone and of the changes they induce in bone remodeling

  2002cites this paper